Ono-Nita, S. K., Kato, N., Shiratori, Y., Carrilho, F. J., & Omata, M. (2002). Novel Nucleoside Analogue MCC-478 (LY582563) Is Effective against Wild-Type or Lamivudine-Resistant Hepatitis B Virus. American Society for Microbiology.
Chicago-стиль цитированияOno-Nita, Suzane Kioko, Naoya Kato, Yasushi Shiratori, Flair José Carrilho, and Masao Omata. Novel Nucleoside Analogue MCC-478 (LY582563) Is Effective against Wild-Type or Lamivudine-Resistant Hepatitis B Virus. American Society for Microbiology, 2002.
MLA-цитированиеOno-Nita, Suzane Kioko, et al. Novel Nucleoside Analogue MCC-478 (LY582563) Is Effective against Wild-Type or Lamivudine-Resistant Hepatitis B Virus. American Society for Microbiology, 2002.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.